 |
|
|
| |
Preclinical Pharmacokinetic and Safety Profile of IDX375, A Novel
and Potent Non-Nucleoside HCV Polymerase Inhibitor
|
| |
| |
44th EASL
Reported by Jules Levin
1S.S. Good, 1C. Bu, 1M. Camire, 1B. Hernandez-Santiago, 1M. Larsson, 1H. Rashidzadeh, 1X.-R. Pan-Zhou, 1S. Luo, 1J. Selden, 2C.B. Dousson and 2D. Surleraux
1Idenix Pharmaceuticals, Inc., Cambridge, MA, USA; 2Idenix Pharmaceuticals, Inc., Montpellier, France
|
| |
|
|
|
|
|
